-
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al. DC
- 1:21-cv-01485
- D. Del.
- Judge: Colm F. Connolly
- Filed: 10/22/2021
- Latest Docket Entry: 05/19/2023
- PACER
- Docket updated daily
3
Plaintiffs
13
Defendants
11
Accused
Products
1
Patent-in-Suit
918
Days in
Litigation
-
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al. DC
- 1:21-cv-01485
- D. Del.
- Judge: Colm F. Connolly
- Filed: 10/22/2021
- Latest Docket Entry: 05/19/2023
- PACER
- Docket updated daily
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
- Patent Information
-
Validity & Enforceability
-
Infringement
Aurobindo Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 27
|
Aurobindo Pharma USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 27
|
Laurus Generics Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 31
|
Laurus Labs Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 31
|
Lifestar Pharma LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 29
|
Mankind Pharma Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 10 mg/5 mg empagliflozin/linagliptin tablets10 mg empagliflozin tablets12.5 mg/1000 mg12.5 mg/1 g empagliflozin and metformin hydrochloride tablets12.5 mg/500 g empagliflozin and metformin hydrochloride tablets25 mg/1000 mg Empagliflozin and Metformin Hydrochloride extended release tablets25 mg/5 mg empagliflozin/linagliptin tablets25 mg empagliflozin tablets5 mg/1 g empagliflozin and metformin hydrochloride tablets5 mg/500 g empagliflozin and metformin hydrochloride tabletsAurobindo Ltd.’s 5 mg/1000 mg | US 11,090,323 B2 | All Asserted Claims |
Infringement
Entry 29
|
